MK-801 reinstates drug-seeking behaviour in cocaine-trained rats

NeuroReport

Volumn 9, Issue 4, 1998, Pages 637-640

  De Vries, Taco J ^a   Schoffelmeer, Anton N M ^a   Binnekade, Rob ^a   Mulder, Arie H ^a   Vanderschuren, Louk J M J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cocaine; Craving; Drug seeking behaviour; Intravenous self administration; MK 801; NMDA receptors; Reinstatement

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; WITHDRAWAL SYNDROME;

EID: 0032498906     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199803090-00014     Document Type: Article

References (26)

1. Karler R, Chaudhry IA, Calder LD et al. Brain Res 537, 76-82 (1990).
2. Wolf ME and Jeziorski M. Brain Res 613, 291-294 (1993).
3. Robinson TE and Berridge KC. Brain Res Rev 18, 247-291 (1993).
4. Trujillo KA and Akil H. Drug Alcohol Dep 38, 139-154 (1995).
5. Vanderschuren LJMJ, Schoffelmeer ANM and De Vries TJ. Life Sci 61, 427-433 (1997).
6. Wolf ME and Khansa MR. Brain Res 562, 164-168 (1991).
7. Wolf ME, White FJ and Hu XT. Behav Pharmacol 4, 429-442 (1993).
8. Beardsley PM, Hayes BA and Balster RL. J Pharmacol Exp Ther 252, 953-939 (1990).
9. Carlezon WA Jr and Wise RA. J Neurosci 16, 3112-3122 (1994).
10. Carlezon, WA Jr and Wise RA. Brain Res 620, 339-342 (1993).
11. Ranaldi R, French E and Roberts DCS. Psychopharmacology 128, 83-88 (1996).
12. Pierce RC, Meil WM and Kalivas PW. Psychopharmacology 133, 188-195 (1997).
13. Herberg LJ and Rose IC. Psychopharmacology 99, 87-90 (1989).
14. Carlezon WA Jr and Wise RA. Psychopharmacology 128, 413-420 (1996).
15. Stewart J, de Wit H and Eikelboom R. Psychol Rev 91, 251-268 (1984).
16. Markou A, Weiss F, Gold LH et al. Psychopharmacology 112, 163-182 (1993).
17. Koek W, Kleven MS and Colpaert FC. Behav Pharmacol 6, 590-600 (1995).
18. Zajaczkowski W, Moryl E and Papp M. Pharmacol Biochem Behav 55, 163-168 (1996).
19. Stewart J and Vezina P. Brain Res 457, 287-294 (1988).
20. Stewart J. Pharmacol Biochem Behav 20, 917-923 (1984).
21. Druhan JP, Rajabi H and Stewart J. Synapse 24, 135-146 (1996).
22. Mathe JM, Nomikos GG, Hildebrand BE et al. Eur J Pharmacol 309, 1-11 (1996).
23. Schmidt CJ and Fadayel GM. J Pharmacol Exp Ther 277, 1541-1549 (1996).
24. Mathe JM, Nomikos GG, Schilstrom B et al. Soc Neurosci Abstr 23, 1091 (1997).
25. Willeins DL, Narayanan S, Wallace, LJ et al. Pharmacol Biochem Behav 46, 881-887 (1993).
26. Zering G, Fabisch K and Fabisch H. Trends Pharmacol Sci 18, 229-231 (1997).